Tower Research Capital (TRC)’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,005
Closed -$381 6469
2023
Q2
$381 Buy
2,005
+1,369
+215% +$260 ﹤0.01% 5642
2023
Q1
$0 Buy
+636
New ﹤0.01% 6585
2022
Q1
Sell
-8,417
Closed -$11K 6865
2021
Q4
$11K Buy
+8,417
New +$11K ﹤0.01% 4496
2021
Q3
Sell
-17,431
Closed -$28K 6367
2021
Q2
$28K Buy
17,431
+12,421
+248% +$20K ﹤0.01% 3583
2021
Q1
$11K Sell
5,010
-20,603
-80% -$45.2K ﹤0.01% 4336
2020
Q4
$64K Sell
25,613
-67,756
-73% -$169K ﹤0.01% 2856
2020
Q3
$230K Buy
93,369
+81,822
+709% +$202K ﹤0.01% 2445
2020
Q2
$41K Buy
+11,547
New +$41K ﹤0.01% 3217
2020
Q1
Sell
-11,515
Closed -$25K 4166
2019
Q4
$25K Buy
11,515
+9,535
+482% +$20.7K ﹤0.01% 1794
2019
Q3
$4K Buy
1,980
+298
+18% +$602 ﹤0.01% 3482
2019
Q2
$2K Sell
1,682
-4,293
-72% -$5.11K ﹤0.01% 3347
2019
Q1
$12K Sell
5,975
-2,145
-26% -$4.31K ﹤0.01% 2604
2018
Q4
$11K Sell
8,120
-901
-10% -$1.22K ﹤0.01% 2423
2018
Q3
$22K Buy
+9,021
New +$22K ﹤0.01% 2295
2018
Q1
Sell
-1,851
Closed -$6K 4073
2017
Q4
$6K Buy
1,851
+141
+8% +$457 ﹤0.01% 2838
2017
Q3
$7K Sell
1,710
-273
-14% -$1.12K ﹤0.01% 3225
2017
Q2
$8K Buy
+1,983
New +$8K ﹤0.01% 1753
2016
Q2
Sell
-73
Closed 5150
2016
Q1
$0 Sell
73
-4,541
-98% ﹤0.01% 5171
2015
Q4
$15K Buy
4,614
+3,875
+524% +$12.6K ﹤0.01% 1638
2015
Q3
$3K Sell
739
-6,428
-90% -$26.1K ﹤0.01% 3194
2015
Q2
$10K Buy
+7,167
New +$10K ﹤0.01% 2725
2014
Q4
Sell
-1,426
Closed -$6K 4889
2014
Q3
$6K Buy
+1,426
New +$6K ﹤0.01% 3202
2013
Q4
Sell
-184
Closed -$1K 5019
2013
Q3
$1K Sell
184
-418
-69% -$2.27K ﹤0.01% 4373
2013
Q2
$3K Buy
+602
New +$3K ﹤0.01% 3348